DR

David Rabuka

Founder, CEO, President at Acrigen Biosciences

Berkeley, California

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Bioconjugation
Protein Engineering
Organic Synthesis
Biochemistry
Protein Chemistry
Drug Discovery
Organic Chemistry
Medicinal Chemistry
Chemistry
Lifesciences
Biotechnology
Purification
Protein Expression
Enzyme Kinetics
Protein Purification
Molecular Biology
Biophysics
Drug Development
Characterization
Immunology

Education

Lists including David

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

AB
Acrigen Biosciences

2019

  • Founder, CEO, President

    2019

CP
Catalent Pharma Solutions

2014 - 2019

  • Global Head of R&D, Chemical Biology

    2014 - 2019

Redwood Bioscience

2008 - 2014

  • Founder, CSO, President

    2008 - 2014

OP
Optimer Pharmaceuticals

2001 - 2004

  • Staff Scientist

    2001 - 2004

    Synthesis of novel aminoglycoside antibiotics, including exploratory research and lead optimization; Design and synthesis of novel carbohydrate building blocks to be used in conjunction with Optimer’s proprietary core technology.

TB
The Burnham Institute

2000 - 2001

  • Research Assistant

    2000 - 2001

    Synthesis of complex carbohydrates and cholesterol derivatives. Developed methodology for sialic acid glycosylation.